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This 6-year-old female patient presented a swelling and tenderness over the right lower face. She had no systemic or congenital diseases. Extraoral ex amination showed that the right cheek was swollen without redness. The cheek mass was soft and painful on palpation. No significant neck masses were identified. Intraorally, the buccal side of the right lower retromolar region was soft on palpation (Fig. 1A) . Computed tomography revealed an osteolytic lesion measuring approximately 2.3 Â 2.0 Â 2.1 cm in size in the right lower retromolar region of the mandible (Fig. 1B) . Whole body bone scan revealed an increased uptake of Tc-99m methylene diophosphate at the right lower jaw (Fig. 1C) . Blood examination demonstrated no abnormal findings. On operation, the right lower second molar was surrounded by the lesion and a bony defect was found on the buccal plate of the mandible after removal of the whole lesion (Fig. 1D) . Histopathological examination of the specimen showed an infiltrate of lymphocytes, eosinophils, and macrophage-like cells in the mandibular bone (Fig. 1E) . Immunohistochemical stain revealed that the macrophages-like cells were CD1a-positive, suggesting that they were Langerhans cells (Fig. 1F) . Therefore, the final diagnosis was Langerhans cell histiocytosis. At the 6-month follow-up, magnetic resonance imaging showed the soft tissue swelling at the right lower jaw subsided. No abnormal neck lymph nodes were observed and no sign of recurrence was noted.
LCH occurs frequently at the age of 2e3-years and is more commonly found in boys than in girls. Bone involvement occurs in most patients and can involve any bone of the body. Although some lesions are asymptomatic, the patient may complain of pain in a localized area of bone. Physical examination usually reveals a raised, soft, and tender mass. Radiological studies typically demonstrate a lytic, punched-out lesion which is occasionally accompanied by a soft tissue mass. Although LCH can be suspected on the basis of clinical and radiographic findings, the final diagnosis must be confirmed by immunohistochemical staining, because the Langerhans cells are positive for CD1a or S100 protein.
2e5 For patients with a single bone lesion, surgical excision of the lesion is the first choice of treatment. Moreover, for those patients with multiple lesions, treatment options include single-agent prednisone, the combination of vinblastine and prednisone, and excision of the bone lesions. 
